ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/26/2026
Back to search
Official data from USPTO
ENDO GENERICS PAR PHARMACEUTICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000097313223Class
5, 10, 40, 41, 42, 44
Filing
97313223
Registration
7052815
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
01/27/2026
Trademark type
Combined
Nice classes
5, 10, 40, 41, 42, 44
Filing date
03/15/2022
Registration date
05/16/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2023
Last transaction
01/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
99
Owner location
BALLSBRIDGE, DUBLIN 4, IE
Examiner
BAGLINI, KAREN
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a hexagon shape on an angle with intermittent solid vertical lines, with the words "ENDO GENERICS" in lower case font to the right and the words "PAR PHARMACEUTICAL" in title case font underneath.
Holders and representatives
Holders
PH HEALTH LIMITED
ENDO OPERATIONS LIMITED
Endo Pharmaceuticals Inc.
Representatives
Camille M. Miller COZEN O'CONNOR
Technical classification
Nice Classes
Class 5Class 10Class 40Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medical preparations and ready-to-administer injectable pharmaceutical and medical preparations in connection with critical carecritical testingmaternal healthanesthesiafor the treatment of painallergic reactionshypotensionshockmalignant diseaseskidney disorderscelluliteskin caredermatological usefoldsscarsbody contouring and for rejuvenating the skinto provide and reverse muscle relaxationall to be used in patient care facilitieshospitalsacute care facilitieslong term care facilities and in doctor's offices; Pharmaceutical preparationsanalgesics and pain management preparationspreparations for the treatment of cancerspreparations for the treatment of urological diseases and disorderspreparations for the treatment of schizophrenia; pharmaceutical preparations for the treatment of asymmetries and defects in conditions of the human skin; pharmaceutical preparations for the treatment of diseases and disorders of the endocrine systemhormone replacement therapy preparations; drug substancesenzymes for medical purposes; pharmaceutical preparations for the treatment of cellulite; pharmaceutical preparations for skin care; medicated gels and creams for dermatological use; nutritional and dietary supplements; vitamins and mineral supplements; food supplements
Class 10
Medical devices for use in treating pelvic disorders; Medical devices for use in treating pelvic organ prolapse; Medical devices for use in treating urinary incontinence; Medical devices for use in pain management and alleviation; Medical devicessurgical equipment in the fields of urology and men's health; Medical devicesintrauterine devices; Injection syringes; Injection device for pharmaceuticals and medicine
Class 40
Manufacture of pharmaceutical products to order and specification of others; Providing technical information in the field of pharmaceutical manufacturing
Class 41
Educational servicesconducting classesseminarsworkshops in the field of pharmaceutical preparations and medicinesmedical devices and techniques; Educational servicesconducting classesseminarsworkshops and training for doctorsnurses and others in the fields of critical carecritical testingmaternal healthrare diseases and conditionsanesthesiaaesthetic solutions to help patients feel better about their bodies
Class 42
Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Medical research in the fields of chemicals and pharmaceuticals; Scientific research and testing services in the fields of chemicals and pharmaceuticals; Research and development of new products for others in the fields of chemicals and pharmaceuticals; Development of pharmaceutical products to specifications of others
Class 44
Providing medical information and online medical information on the subjects of pharmaceutical preparations and medicinesmedical devices and techniques; Providing medical information and online medical and healthcare information to healthcare professionals and patients; Providing a website featuring medical information; Providing medication counseling informationadvice and data on the subjects of pharmaceutical preparations and medicine
Publications
History of USPTO decisions and trademark events.
27 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/02/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/14/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/01/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/16/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2023
PUBO
PUBLISHED FOR OPPOSITION
02/28/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/20/2023
ALIE
ASSIGNED TO LIE
01/19/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/18/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/23/2022
GNSL
LETTER OF SUSPENSION E-MAILED
08/23/2022
CNSL
SUSPENSION LETTER WRITTEN
08/23/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/02/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/02/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/16/2022
GNRT
NON-FINAL ACTION E-MAILED
05/16/2022
CNRT
NON-FINAL ACTION WRITTEN
05/16/2022
DOCK
ASSIGNED TO EXAMINER
05/10/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/21/2022
NWAP
NEW APPLICATION ENTERED
03/18/2022
Continuous trademark protection
Get notified about every new filing that threatens ENDO GENERICS PAR PHARMACEUTICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.